Chen received her BSc in physics from the National Taiwan University in 1981, and her PhD in applied physics from Harvard University (1989). Then, she worked at the General Electric Corporate R&D, Schenectady, New York (1989–1994), joined the Center for Condensed Matter Sciences (CCMS), NTU in 1994, and became a professor with the Physics Department in 2021. Chen was the director of CCMS (2012–2018), and since 2018 has been the director of the Center of Atomic Initiative for New Materials, a research centre featured by the Sprout Project under the Ministry of Education (MoE) in Taiwan. Chen’s group is specialized in low-dimensional nanomaterials and their applications for optoelectronics and energy. She is a Fellow of both the Physical Society and the Vacuum Society in Taiwan, and the Materials Research Society in USA. She has received numerous honours that include a Laureate of the 22nd Khwarizmi International Award, the Outstanding Research Award by the National Science and Technology Council (twice), the MoE Academic Award, and the Taiwan Outstanding Women in Science. Chen was elected as an Academician of the Asia Pacific Academy of Materials and Academician of Academia Sinica.

Hung, PhD, is president for China Medical University and chancellor for China Medical University - Asia University System in Taichung, Taiwan. He was vice-president for basic research and professor and chair of the Department of Molecular and Cellular Oncology at the MD Anderson Cancer Center, The University of Texas. Hung is a basic scientist with a keen translational vision and especially his recent research effort has significantly contributed to understanding the biology of cancer and to developing combinational cancer therapies to overcome resistance. Up to date, Hung has published more than 600 peer-reviewed articles, of which over 160 were published in journals with impact factor 10 or above. His lifetime h-index reaches to 163 (Google Scholar). He is one of the members of the selection committee for Tang Prize in Biopharmaceutical Science category, and is one of the founding editorial members for Cancer Cell (2002–2020). He serves as member, Molecular Cell Advisory Board (2020–present); senior editor, Cancer Research (2018–2021); editor-in-chief, American Journal for Cancer Research (AJCR) (2015–2017; 2020–present); editor, Cancer and Metastasis Reviews (2018–present).